EPIS B — Episurf Medical AB Share News
0.000.00%
Last trade - 00:00- SEK438.03m
- SEK700.73m
- SEK13.50m
Brief: Episurf Medical: Restructuring Program Completed With Planned Cost Reduction Expected 2024
Brief: Episurf Q4 EPS SEK -0.08
Brief: New Patent Approvals For Episurf Medical
Brief: Episurf Says Expansion Of Business Model Shows Progress
Brief: Episurf Q3 EPS SEK -0.08
Brief: Episurf Medical: Strategy Update To Take The Next Commercial Steps And Improve Financial Results
Brief: Episurf Q2 Sales at SEK 2.2 Million
Brief: Episurf Medical Gets Approval For Episealer® Patellofemoral System
Brief: Episurf Q1 Sales at SEK 2.5 Million
Brief: Episurf Medical Gets New Canadian Patent Approval
Brief: Episurf Gets New Indian Patent Approval
Brief: Episurf Medical Gets New Patent Approval In U.S.
Brief: Episurf Q4 Orders SEK 2.2 Million
Brief: Episurf Medical Chairman Dennis Stripe Will Not Stand For Re-Election
Brief: New U.S. Patent Approval For Episurf Medical
Brief: Episurf Medical Says Receives FDA 510(K) Clearance For Episealer® Patellofemoral System
Brief: Episurf Medical AB Q3 Loss SEK 17.8 Million
Brief: Episurf Medical Updates On 510(K) Application
Brief: Episurf Medical Receive New US Patent Approval